Lymphoma, Primary Effusion: Clinical Trials

3 trials for Lymphoma, Primary Effusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 11Completed 1

Follow Lymphoma, Primary Effusion: new trials by email Literature Review of Lymphoma, Primary Effusion trials Research Report on Lymphoma, Primary Effusion

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903
HST-NEETs, Bone Marrow Transplant - HIV Associated Lymphoma
Phase 2CompletedCatherine Bollard122021-10-252026-06-29
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide - AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)1072010-10-062023-11-21
Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
carmustine, cyclophosphamide, etoposide - Lymphoma
Phase 2CompletedMasonic Cancer Center, University of Minnesota4732005-08-242020-07-14

Narrower conditions

HIV Infections (1)  ·  Hodgkin Disease (1)  ·  Lymphoma (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Plasmablastic Lymphoma (1)

Broader conditions

Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Lymphatic Diseases (3)  ·  Lymphoma, B-Cell (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Lymphoma (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)

Interventions

Cyclophosphamide (2)  ·  Etoposide (2)  ·  Bone Marrow Transplantation (1)  ·  CT-P10 (1)  ·  Carmustine (1)  ·  Cytarabine (1)  ·  Doxorubicin (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Prednisone (1)  ·  Rituximab (1)  ·  Vincristine (1)  ·  Vorinostat (1)  ·  deltacortene (1)

Sponsors

Catherine Bollard (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (3)

Top investigators

Juan C Ramos (1)  ·  Steve Devine, MD, MS (1)  ·  Veronika Bachanova, MD (1)

Results publications

PMID 32430507

NIH funding

U10HL069294 (1), UM1CA121947 (1)